Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%) Dr. Reddy’s Laboratories informs about press release
Date: 19-06-2018Dr. Reddy’s Laboratories has informed about press release titled ‘Dr. Reddy's Laboratories announces the launch of Levetiracetam in Sodium Chloride Injection in the US Market’.
The above information is a part of company’s filings submitted to BSE.